FibroBiologics moves experimental psoriasis therapy into FDA review
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
Theracor is derived from human umbilical cord extracellular matrix (ECM) and is designed to cover, protect, and maintain a moist wound environment
TMS offers new hope to patients suffering from stroke, migraine, neuropathic pain, depression, and other disorders
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
Tolebrutinib had been provisionally approved in the United Arab Emirates in July 2025 for nrSPMS to slow disability accumulation independent of relapse activity
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
Subscribe To Our Newsletter & Stay Updated